• Username (E-mail)
  • Password
Dow 19,800 -0.1%  EStoxx50 3,281 0.3%  Nikkei 18,788 -0.6%  EUR 1.0731 -0.3% 
Nasdaq 5,553 0.0%  FTSE100 7,172 0.3%  Yen 113.3740 0.7%  Oil 55.5 0.2% 
S&P500 2,265 -0.3%  DAX 11,575 0.3%  GBP 1.2448 -0.7%  Gold 1,212 -0.6% 

Fresenius share [ISIN: DE0005785604]

01/10/2017 09:03:50 AM
01/10/2017 09:03:50 AM UTC-0500

Fresenius SE & Co. KGaA (St.) Buy

The analysts of Independent Research GmbH have rated Fresenius with a Buy rating. The price target was set to 84.00 €. At a current price of the Fresenius stock of 73.37 € this means an upside potential of 14.49%.
Summary: Fresenius SE & Co. KGaA (St.) Buy
Company:
Fresenius SE & Co. KGaA (St.)
Analyst:
Independent Research GmbH
Price Target:
84.00 €
Current Rating:
Buy
Price*:
73.41 €
Distance to Target Price*:
14.43%
Previous Rating:
-
Latest Price:
73.37 €
Distance Price Target:
14.49%
Analyst Name::
Bernhard Weininger
P/E Ratio*:
-

News for Fresenius SE & Co. KGaA (St.)

More News
  • Relevant
  • All
  • Company News
No news available.

Analyst Opinions for Fresenius SE & Co. KGaA (St.)

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/18/17
Fresenius Citigroup Corp.
01/11/17
Fresenius Commerzbank AG
01/10/17
Fresenius Independent Research GmbH
01/09/17
Fresenius DZ BANK
01/04/17
Fresenius Citigroup Corp.

Add or Edit Instrument

Related Stocks

Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.